2021
One year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut
Morozova O, Li ZR, Crawford FW. One year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut. Scientific Reports 2021, 11: 20271. PMID: 34642405, PMCID: PMC8511264, DOI: 10.1038/s41598-021-99590-5.Peer-Reviewed Original ResearchMeSH KeywordsConnecticutCOVID-19ForecastingHumansModels, StatisticalPandemicsPublic Health SurveillanceConceptsCOVID-19 disease progressionSARS-CoV-2 transmissionCase detection ratioPublic health surveillancePublic health policymakersInfection hospitalizationsCumulative incidenceEpidemiologic featuresClinical progressionCOVID-19 transmissionCOVID-19 projectionsDisease progressionFatality ratioHospital dataEffective reproduction numberHospitalizationHealth surveillanceTransmission riskSEIR-type modelHealth policymakersCOVID-19 epidemicEpidemic trajectoriesDisease transmissionInfectionProgression
2019
Cost‐effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis
Morozova O, Crawford FW, Cohen T, Paltiel AD, Altice FL. Cost‐effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis. Addiction 2019, 115: 437-450. PMID: 31478285, PMCID: PMC7015766, DOI: 10.1111/add.14797.Peer-Reviewed Original ResearchConceptsOpioid agonist treatmentOpioid use disorderOAT coverageAgonist treatmentGross domestic productOpioid use initiationOpioid addiction epidemicOAT accessHIV epidemicUse disordersAddiction epidemicCapita gross domestic productPay thresholdsTreatment demandUse initiationAddiction treatmentIncremental costBaseline capacityTreatmentPotential peer effectsDomestic productTreatment spilloversEpidemicPeer effectsCoverage levels